Skip to main content
Premium Trial:

Request an Annual Quote

Guardant Health Providing Liquid Biopsy for Japanese GI Cancer Basket Trial

NEW YORK (GenomeWeb) – Guardant Health said today that its Guardant360 liquid biopsy assay will be used in a large ongoing trial organized by the National Cancer Center Hospital East (NCCE) in Kashiwa, Japan.

The study is matching patients with advanced gastrointestinal cancer, including gastric and colorectal cancer, to novel therapies that target specific gene alterations. The liquid biopsy arm, called GOZILA (Guardant Originates in ZIpangu Liquid biopsy Arrival) will initially use Guardant360 to test 200 advanced CRC patients whose cancer has progressed after standard treatment with anti-EGFR therapy.

Those who test positive for amplification in the ERBB2 gene will be enrolled in a clinical trial exploring the effectiveness of changing to an anti-ERBB2 combination targeted therapy with trastuzumab and pertuzumab. The study will then expand to include 2,000 patients with a variety of GI cancers and treatment arms.

The study is part of a larger effort in Japan, called SCRUM-Japan GI-SCREEN, to assess the genomic profile of patients with advanced cancer in their GI tracts and match them to associated targeted therapies.

"Tumors that metastasize from the GI tract can be especially difficult to access, making tissue specimen collection challenging. Through a simple blood draw, we can help match these patients to the experimental treatments being studied by NCCE Japan," Guardant Health CEO Helmy Eltoukhy said in a statement.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.